RAPT
Rapt Therapeutics Inc
Price:  
11.68 
USD
Volume:  
162,921.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RAPT Relative Valuation

-936.3%
Upside

As of 2025-07-19, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (97.68) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.68 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -936.3%.

The range of the Relative Valuation is (74.75) - (136.24) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.6x - 18.5x 13.0x
Forward P/E multiples 10.1x - 21.0x 13.5x
Fair Price (74.75) - (136.24) (97.68)
Upside -740.0% - -1266.4% -936.3%
11.68 USD
Stock Price
(97.68) USD
Fair Price

RAPT Relative Valuation - Historical P/E Data

Date P/E
2025-07-16 -1.43
2025-07-15 -1.44
2025-07-14 -1.18
2025-07-11 -1.15
2025-07-10 -1.17
2025-07-09 -1.14
2025-07-08 -1.09
2025-07-07 -1.11
2025-07-03 -1.09
2025-07-02 -1.09
2025-07-01 -0.99
2025-06-30 -1.09
2025-06-27 -1.14
2025-06-26 -1.32
2025-06-25 -1.30
2025-06-24 -1.11
2025-06-23 -1.01
2025-06-20 -1.01
2025-06-18 -1.01
2025-06-17 -1.06
2025-06-16 -1.12
2025-06-13 -1.13
2025-06-12 -1.18
2025-06-11 -1.19
2025-06-10 -1.29
2025-06-09 -1.30
2025-06-06 -1.27
2025-06-05 -1.11
2025-06-04 -1.11
2025-06-03 -1.07
2025-06-02 -1.02
2025-05-30 -0.96
2025-05-29 -1.01
2025-05-28 -1.06
2025-05-27 -1.06
2025-05-23 -1.33
2025-05-22 -0.93
2025-05-21 -0.96
2025-05-20 -1.05
2025-05-19 -1.05
2025-05-16 -0.91
2025-05-15 -0.88
2025-05-14 -0.81
2025-05-13 -0.81
2025-05-12 -0.95
2025-05-09 -0.82
2025-05-08 -0.87
2025-05-07 -0.87
2025-05-06 -0.88
2025-05-05 -0.99